title: Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: preliminary results.
authors.affiliation: French Society for Bone Marrow Transplantation, Hôpital Haut-Levêque, Pessac.
authors.forename: J
authors.initials: J
authors.lastname: Reiffers
authors.forename: J Y
authors.initials: JY
authors.lastname: Cahn
authors.forename: M
authors.initials: M
authors.lastname: Montastruc
authors.forename: D
authors.initials: D
authors.lastname: Caillot
authors.forename: G
authors.initials: G
authors.lastname: Souillet
authors.forename: V
authors.initials: V
authors.lastname: Leblond
authors.forename: J
authors.initials: J
authors.lastname: Troncy
authors.forename: C
authors.initials: C
authors.lastname: Faberes
mesh_terms: D000293:Adolescent; D000328:Adult; D001804:Blood Transfusion, Autologous / Q000009:adverse effects; D002648:Child; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins; D015996:Survival Rate
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins